TrialGynecologic oncology2018

Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.

Alexander B Olawaiye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.